3 ms·
Tirzepatide will have FDA approval for obesity this year. GP’s dogmatic stance that “Mounjaro is not an obesity drug!!” is overwhelmingly rejected by the availa
by runnerup 4y ago
Tirzepatide will have FDA approval for obesity this year. GP’s dogmatic stance that “Mounjaro is not an obesity drug!!” is overwhelmingly rejected by the available evidence.